Home » Opioid-induced Constipation Therapy Approved by FDA
Opioid-induced Constipation Therapy Approved by FDA
July 27, 2016
The FDA has approved a new drug co-developed by Valeant Pharmaceuticals and Progenics Pharmaceuticals that treats opioid-induced constipation in adults.
Relistor is slated to hit the market sometime this fall, the companies said.
Upcoming Events
-
21Oct